{"id":10099,"date":"2026-02-12T01:12:16","date_gmt":"2026-02-12T01:12:16","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/10099\/"},"modified":"2026-02-12T01:12:16","modified_gmt":"2026-02-12T01:12:16","slug":"novo-nordisk-target-cut-by-deutsche-bank-despite-long-term-optimism-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/10099\/","title":{"rendered":"Novo Nordisk target cut by Deutsche Bank despite long-term optimism"},"content":{"rendered":"<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/02\/1770858736_308_f5140ea9b2861fec8d3b2f1e6d051550.jpeg\" alt=\"Novo Nordisk target cut by Deutsche Bank despite long-term optimism\" loading=\"eager\" height=\"720\" width=\"960\" class=\"yf-lglytj  loaded\"\/> Novo Nordisk target cut by Deutsche Bank despite long-term optimism Proactive uses images sourced from Shutterstock      <\/p>\n<p class=\"yf-vbsvxt\">Deutsche Bank has cut its price target for <a href=\"https:\/\/finance.yahoo.com\/quote\/NVO\" data-ylk=\"slk:Novo Nordisk (NYSE:NVO);elm:context_link;itc:0;sec:content-canvas\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">Novo Nordisk (NYSE:NVO)<\/a> by 16% to DKK400 following a turbulent week for the Danish pharmaceutical group, citing revenue headwinds, management uncertainty and clinical trial risks.<\/p>\n<p class=\"yf-vbsvxt\">Emmanuel Papadakis, equity analyst at Deutsche Bank, described the period post fourth-quarter results as \u201cthe best of times, the worst of times\u201d, reflecting a mix of strong product potential and acute business volatility.<\/p>\n<p class=\"yf-vbsvxt\">He warned of a \u201cdouble-digit revenue decline\u201d in the current year, but said the stock was back to trading at a \u201cmid-teens price-to-earnings ratio\u201d, supported by the launch of its oral obesity treatment and possible demand recovery in the second half.<\/p>\n<p class=\"yf-vbsvxt\">\u201cWe are clear-eyed that the volatility is tough to stomach, the management situation remains fluid, business visibility is limited and there remains a clear downside scenario,\u201d Papadakis said, adding that data from trials of CagriSema, a key obesity treatment candidate, would be critical.<\/p>\n<p class=\"yf-vbsvxt\">Despite the target cut, Deutsche Bank reiterated its &#8216;buy&#8217; rating.<\/p>\n<p class=\"yf-vbsvxt\">In mid-afternoon, the shares were off 2.4% to DKK307.55.<\/p>\n<p class=\"yf-vbsvxt\">\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk target cut by Deutsche Bank despite long-term optimism Proactive uses images sourced from Shutterstock Deutsche Bank&hellip;\n","protected":false},"author":2,"featured_media":10100,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[7622,7623,272,1442,3696,7624],"class_list":["post-10099","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-deutsche-bank","tag-emmanuel-papadakis","tag-novo-nordisk","tag-obesity-treatment","tag-revenue-decline","tag-target"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/10099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=10099"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/10099\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/10100"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=10099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=10099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=10099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}